High Creatinine Level Secondary to Use of CDK 4/6 Inhibitor Treatment (Palbociclib and Ribociclib) + Endocrine Therapy (ET).

Autor: Keskinkilic M; Department of Medical Oncology, Dokuz Eylul University, Izmir, Turkiye., Semiz HS; Department of Medical Oncology, Dokuz Eylul University, Izmir, Turkiye., Yavuzsen T; Department of Medical Oncology, Dokuz Eylul University, Izmir, Turkiye., Karaoglu A; Department of Medical Oncology, Dokuz Eylul University, Izmir, Turkiye.

Publikováno v: Journal of the College of Physicians and Surgeons--Pakistan : JCPSP [J Coll Physicians Surg Pak] 2024 Jul; Vol. 34 (7), pp. 851-853.

The prognostic value of immune-nutritional status in metastatic colorectal cancer: Prognostic Nutritional Index (PNI).

Autor: Keskinkilic M; Department of Medical Oncology, Faculty of Medicine, Dokuz Eylul University, Izmir, Turkey. mervekeskinkilic90@gmail.com., Semiz HS; Department of Medical Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey., Ataca E; Deparment of Internal Medicine, Mus State Hospital, Mus, Turkey., Yavuzsen T; Department of Medical Oncology, Institute of Oncology, Dokuz Eylul University, Izmir, Turkey.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 May 23; Vol. 32 (6), pp. 374. Date of Electronic Publication: 2024 May 23.

Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia on efficacy: a Turkish Oncology Group (TOG) study.

Autor: Yildirim HC; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.; Department of Medical Oncology, Nigde Research and Education Hospital, Nigde, Turkey., Kapar C; Department of Medical Oncology, Bakırkoy Dr. Sadi Konuk Education and Research Hospital, İstanbul, Turkey., Koksal B; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Seyyar M; Department of Medical Oncology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey., Sanci PC; Department of Medical Oncology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey., Guliyev M; Department of Medical Oncology, Istanbul Cerrahpasa University Faculty of Medicine, Istanbul, Turkey., Perkin P; Department of Medical Oncology, Yildirim Beyazit University, Bilkent State Hospital, Ankara, Turkey., Buyukkor M; Department of Medical Oncology, Dr. A. Y. Ankara Oncology Research and Education Hospital, University of Health Sciences, Ankara, Turkey., Yaslikaya S; Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana, Turkey., Majidova N; Department of Medical Oncology, Marmara University Faculty of Medicine, Istanbul, Turkey., Keskinkilic M; Department of Medical Oncology, 9 Eylül University Faculty of Medicine, Izmir, Turkey., Ozaskin D; Department of Medical Oncology, Afyon Health Sciences University School of Medicine, Afyonkarahisar, Turkey., Avci T; Department of Medical Oncology, Celal Bayar University Faculty of Medicine, Manisa, Turkey., Gunes TK; Department of Medical Oncology, Umraniye Research and Education Hospital, Istanbul, Turkey., Arcagok M; Department of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir, Turkey., Topal A; Department of Medical Oncology, University of Health Sciences, Gulhane School of Medicine, Ankara, Turkey., Keskin GSY; Department of Medical Oncology, University of Health Sciences, Gulhane School of Medicine, Ankara, Turkey., Kavgaci G; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Yildirim N; Department of Medical Oncology, Firat University Faculty of Medicine, Elazig, Turkey., Celayir OM; Department of Medical Oncology, Acibadem University Faculty of Medicine, Istanbul, Turkey., Avci N; Department of Medical Oncology, Medicana Hospital, Bursa, Turkey., Aslan F; Department of Medical Oncology, Medical Park Ankara Hospital, Ankara, Turkey., Alkan A; Department of Medical Oncology, Mugla Sitki Kocman University Faculty of Medicine, Mugla, Turkey., Erciyestepe M; Department of Medical Oncology, Istanbul Prof. Dr. Cemil Tascioglu State Hospital, Istanbul, Turkey., Cengiz M; Department of Medical Oncology, Erciyes University Faculty of Medicine, Kayseri, Turkey., Pehlivan M; Department of Medical Oncology, Zonguldak Ataturk State Hospital, Zonguldak, Turkey., Gulmez A; Department of Medical Oncology, Adana City Education and Research Hospital, Adana, Turkey., Beypinar I; Department of Medical Oncology, Alaaddin Keykubat University Faculty of Medicine, Antalya, Turkey., Basoglu Tuylu T; Department of Medical Oncology, Nigde Research and Education Hospital, Nigde, Turkey., Kayikcioglu E; Department of Medical Oncology, Isparta Suleyman Demirel University Faculty of Medicine, Isparta, Turkey., Chalabiyev E; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey., Turhal S; Department of Medical Oncology, Anadolu Health Center, Istanbul, Turkey., Guzel HG; Department of Medical Oncology, Antalya Education and Research Hospital, Antalya, Turkey., Ayas E; Department of Medical Oncology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey., Sahbazlar M; Department of Medical Oncology, Celal Bayar University Faculty of Medicine, Manisa, Turkey., Dulgar O; Department of Medical Oncology, Umraniye Research and Education Hospital, Istanbul, Turkey., Demir H; Department of Medical Oncology, Afyon Health Sciences University School of Medicine, Afyonkarahisar, Turkey., Yavuzsen T; Department of Medical Oncology, 9 Eylül University Faculty of Medicine, Izmir, Turkey., Bayoglu V; Department of Medical Oncology, Marmara University Faculty of Medicine, Istanbul, Turkey., Kivrak Salim D; Department of Medical Oncology, Antalya Education and Research Hospital, Antalya, Turkey., Ozturk B; Department of Medical Oncology, Antalya Education and Research Hospital, Antalya, Turkey., Ozdemir F; Department of Medical Oncology, Karadeniz Technical University Faculty of Medicine, Trabzon, Turkey., Kara O; Department of Medical Oncology, Cukurova University Faculty of Medicine, Adana, Turkey., Oksuzoglu B; Department of Medical Oncology, Dr. A. Y. Ankara Oncology Research and Education Hospital, University of Health Sciences, Ankara, Turkey., Bal O; Department of Medical Oncology, Yildirim Beyazit University, Bilkent State Hospital, Ankara, Turkey., Demirci NS; Department of Medical Oncology, Istanbul Cerrahpasa University Faculty of Medicine, Istanbul, Turkey., Yilmaz M; Department of Medical Oncology, Bakırkoy Dr. Sadi Konuk Education and Research Hospital, İstanbul, Turkey., Cabuk D; Department of Medical Oncology, Kocaeli University Faculty of Medicine, Kocaeli, Turkey., Aksoy S; Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.

Publikováno v: Journal of chemotherapy (Florence, Italy) [J Chemother] 2024 Mar 18, pp. 1-7. Date of Electronic Publication: 2024 Mar 18.

The comparison of functional status and health-related parameters in ovarian cancer survivors with healthy controls.

Autor: Gultekin SC; Faculty of Physical Therapy and Rehabilitation, Graduate School of Health Sciences, Dokuz Eylul University, Izmir, Turkey. cnsgultekin@gmail.com., Cakir AB; Faculty of Physical Therapy and Rehabilitation, Graduate School of Health Sciences, Dokuz Eylul University, Izmir, Turkey., Guc ZG; Department of Medical Oncology, Izmir Katip Celebi University, Izmir, Turkey., Ozalp FR; Department of Cardiopulmonary Physiotherapy-Rehabilitation, Faculty of Physical Therapy and Rehabilitation, Dokuz Eylul University, Izmir, Turkey., Keskinkilic M; Department of Cardiopulmonary Physiotherapy-Rehabilitation, Faculty of Physical Therapy and Rehabilitation, Dokuz Eylul University, Izmir, Turkey., Yavuzsen T; Department of Cardiopulmonary Physiotherapy-Rehabilitation, Faculty of Physical Therapy and Rehabilitation, Dokuz Eylul University, Izmir, Turkey., Yavuzsen HT; Clinic of Gynecology and Obstetrics, Buca Obstetrics Gynecology and Pediatrics Disease Hospital, Izmir, Turkey., Karadibak D; Department of Cardiopulmonary Physiotherapy-Rehabilitation, Faculty of Physical Therapy and Rehabilitation, Dokuz Eylul University, Izmir, Turkey.

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2024 Jan 22; Vol. 32 (2), pp. 119. Date of Electronic Publication: 2024 Jan 22.

251P The effect of hormone receptor positive percentage on treatment response and prognosis in HR+ HER2- metastatic breast cancer receiving CDK 4/6 inhibitor + endocrine treatment

Autor: Keskinkilic, M., Semiz, H.S., Yavuzsen, T., Oztop, I.

Publikováno v: In ESMO Open May 2023 8(1) Supplement 4